重组小鼠TREM-2b(髓细胞触发受体2b)(C端带Fc标签

特别提示：包括重组小鼠TREM-2b(髓细胞触发受体2b)(C端带Fc标签)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组小鼠TREM-2b(髓细胞触发受体2b)(C端带Fc标签)
英文名称：Recombinant Mouse Triggering Receptor Expressed on Myeloid Cells 2b
产品货号：JN1534
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Leu19-Pro168在C端带有Fc标签。

TREM-2b质量控制：＞95%(还原性SDS-PAGE)

TREM-2b制剂：冻干品

TREM-2b保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

TREM-2b复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于TREM-2b：
Triggering receptor expressed on myeloid cells-2 (TREM-2) is a cell surface receptor primarily expressed on macrophages, osteoclasts, microglia and dendritic cells. TREM-2 is one member of the TREM family, inhibiting the releasing of inflammatory mediators, so it is an important in vivo anti-inflammatory receptor. TREM-2 consists of an 18 aa signal sequence, a 153 aa extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa transmembrane (TM) domain, and a 35 aa cytoplasmic tail. A soluble form of TREM-2 (TREM-2b) created by alternate splicing diverges at aa 161. TREM-2 transduces intracellular signals through the adaptor DAP12. After binding of TREM-2 with ligand, the TREM-2/DAP12 (dead-cell-activated-receptor-associated protein)-mediated signal transduction pathway causes a series of intracellular protein tyrosine phosphorylation reactions and enzymatic reactions, which then activate the myeloid cells and participate T cell responses.

我公司销售的重组小鼠TREM-2b(髓细胞触发受体2b)(C端带Fc标签)，重组小鼠Triggering Receptor Expressed on Myeloid Cells 2b，重组TREM-2b，重组小鼠髓细胞触发受体2b，重组髓细胞触发受体2b，重组小鼠TREM-2b，rmTREM-2b，重组Triggering Receptor Expressed on Myeloid Cells 2b，rTREM-2b，Recombinant Mouse Triggering Receptor Expressed on Myeloid Cells 2b质量上佳，价格普惠，欢迎广大新老客户踊跃订购。